Clezutoclax
Clezutoclax is a potent and selective Bcl-XL inhibitor, making it an effective payload for antibody-drug conjugate (ADC) development. It is used in cancer research to study apoptosis induction in vitro and evaluate targeted tumor therapy in vivo.
Product Specifications
CAS Number
1949843-71-3
Field of Research
Cell Biology
Smiles
C (C12CC3 (OCCN (C (OCC4=C (CC[C@@H]5O[C@H] (C (O) =O) [C@@H] (O) [C@H] (O) [C@H]5O) C=C (NC ([C@@H] (NC ([C@@H] (NC (CN6[C@H] (COCCS (=O) (=O) O) C[C@@H] (C6=O) N7C (=O) C=CC7=O) =O) [C@H] (C) C) =O) C) =O) C=C4) =O) CC[C@@H] (CO) O) CC (C) (C1) CC (C) (C2) C3) N8C (C) =C (C=N8) C9=C (C (O) =O) N=C (C=C9) N%10CC%11=C (C (NC%12=NC=%13C (S%12) =CC=CC%13) =O) C=CC=C%11CC%10
Molecular Formula
C83H102N12O24S2
Molecular Weight
1715.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
